Premium
Polydopamine‐Incorporated Nanoformulations for Biomedical Applications
Author(s) -
Zheng Pan,
Ding Binbin,
Li Gao
Publication year - 2020
Publication title -
macromolecular bioscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 105
eISSN - 1616-5195
pISSN - 1616-5187
DOI - 10.1002/mabi.202000228
Subject(s) - photothermal therapy , photoacoustic imaging in biomedicine , nanotechnology , drug delivery , biocompatibility , photodynamic therapy , optical imaging , biomedical engineering , materials science , medicine , chemistry , physics , organic chemistry , optics , metallurgy
Polydopamine (PDA), a pigment in natural melanin, has attracted considerable attention because of its excellent optical properties, extraordinary adhesion, and good biocompatibility, which make it a promising material for application in energy, environmental, and biomedical fields. In this review, PDA‐incorporated nanoformulations are focused for biomedical applications such as drug delivery, bioimaging, and tumor therapy. First, the recent advances in PDA‐incorporated nanoformulations for drug delivery are discussed. Further, their application in boimaging, such as fluorescence imaging, photothermal imaging, and photoacoustic imaging, is reviewed. Next, their therapeutic applications, including chemotherapy, photodynamic therapy, photothermal therapy, and synergistic therapy are discussed. Finally, other biomedical applications of PDA‐incorporated nanoformulations such as biosensing and clinical diagnosis are briefly presented. Finally, the biomedical applications of PDA‐incorporated nanoformulations along with their prospects are summarized.